One exception to this rule is for metronidazole and tinidazole, prodrugs that are activated in the bacterial cell by bacterial enzymes.

Objective: To describe emergent therapies, such as rifaximin, nitazoxanide, intravenous immunoglobulin (IVIG), tinidazole, tolevamer, and the possible use of a vaccine, in Clostridium difficile ...